HALOZYME THERAPEUTICS, INC. Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2024.
  • Halozyme Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $127M, a 0.68% decline year-over-year.
  • Halozyme Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $470M, a 0.15% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Costs and Expenses for 2023 was $492M, a 25.2% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Costs and Expenses for 2022 was $393M, a 135% increase from 2021.
  • Halozyme Therapeutics, Inc. annual Costs and Expenses for 2021 was $167M, a 35.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $470M $127M -$867K -0.68% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $471M $114M -$12.5M -9.85% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $484M $100M -$8M -7.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $492M $129M +$22M +20.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $470M $128M +$2.07M +1.65% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $468M $127M +$8.28M +7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $459M $108M +$66.7M +160% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $393M $107M +$61.5M +135% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $331M $126M +$85.4M +212% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $246M $118M +$74.9M +173% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $171M $41.6M +$3.32M +8.68% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $167M $45.5M +$1.39M +3.15% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $166M $40.2M +$15.2M +60.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $151M $43.4M +$17.7M +69.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $133M $38.3M +$9.71M +34% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $123M $44.1M -$41.6M -48.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $165M $25M -$45.8M -64.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $211M $25.7M -$27.5M -51.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $238M $28.6M -$25.4M -47.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $264M $85.7M +$25.4M +42.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $238M $70.8M +$19.7M +38.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $218M $53.1M -$2.15M -3.89% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $221M $54M -$601K -1.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $221M $60.3M -$3.33M -5.24% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $225M $51M -$4.62M -8.31% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $229M $55.3M -$3.95M -6.67% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $233M $54.6M -$2.51M -4.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $236M $63.6M +$16.9M +36.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $219M $55.7M +$1.06M +1.94% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $218M $59.2M +$4.17M +7.57% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $214M $57.1M -$1.57M -2.68% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $215M $46.8M -$14.8M -24.1% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-28
Q3 2016 $230M $54.6M $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $230M $55.1M $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $230M $58.7M $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $230M $61.6M +$27.4M +79.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 $203M $54.6M +$21M +62.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 $182M $55.1M +$21.7M +65.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 $160M $58.7M +$21.5M +57.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 $138M $34.2M +$406K +1.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $138M $33.6M -$875K -2.54% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $139M $33.3M -$3.25M -8.88% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $142M $37.2M +$6.86M +22.6% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $135M $33.8M +$7.62M +29.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 $128M $34.5M +$9.14M +36% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $118M $36.6M +$14.8M +67.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 $104M $30.3M +$7.75M +34.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 $96M $26.2M +$5.36M +25.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 $90.6M $25.4M +$7.57M +42.6% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-28
Q2 2012 $83M $21.8M +$1.71M +8.52% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-28
Q1 2012 $81.3M $22.6M +$5.38M +31.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-28
Q4 2011 $75.9M $20.8M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 $17.8M +$1.96M +12.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 $20.1M +$4.73M +30.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 $17.2M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q3 2010 $15.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $15.4M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.